372
Participants
Start Date
June 21, 2021
Primary Completion Date
June 30, 2024
Study Completion Date
September 30, 2024
Alteplase
Patients will receive standard dose intravenous alteplase (0.9 mg per kilogram, the first 10% administered as an initial bolus and the remainder over a 1-hour period, with a maximum dose of 90 mg)
Wuwei People's Hospital, Wuwei
Chongqing University Jiangjin Hospital, Chongqing
Binjiang Campus of Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou
Bo Ao Campus of Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou
Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou
Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou
Huzhou Central Hospital, Huzhou
First Affiliated Hospital of Jiaxing University, Jiaxing
Second Affiliated Hospital of Jiaxing University, Jiaxing
The First People's Hospital of Jiashan, Jiaxing
The Forth Affiliated Hospital of Zhejiang University, Jinhua
Affiliated Hospital of West Anhui Health Vocational College, Liuan
Mianyang Hospital of TCM, Mianyang
The First People's Hospital of Mianyang (SiChuan Mianyang 404 Hospital), Mianyang
Nanjing Lishui District Hospital of Traditional Chinese Medicine, Nanjing
Ningbo No. 2 Hospital, Ningbo
Zhongshan Hospital, Shanghai
Shaoxing People's Hospital (Shaoxing Hospital of Zhejiang University), Shaoxing
Suzhou Hospital of Anhui Medical University, Suzhou
The First Affiliated Hospital of Soochow University, Suzhou
Taizhou First People's Hospital, Taizhou
The First People's Hospital of Wenling, Taizhou
First Affiliated Hospital of Wenzhou Medical University, Wenzhou
Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou
The People's Hospital of Danyang, Zhenjiang
Zhongshan City People's Hospital, Zhongshan
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER